Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-332730
Filing Date
2026-08-04
Accepted
2026-08-04 16:01:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d141279d424b5.htm 424B5 257738
2 GRAPHIC g141279g01c01.jpg GRAPHIC 73853
3 GRAPHIC g141279g04a04.jpg GRAPHIC 37107
  Complete submission text file 0001193125-26-332730.txt   399042
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273794 | Film No.: 261238370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)